Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank89
3Y CAGR-8.7%
Studio
Year-over-Year Change

Year-over-year net income growth rate

3Y CAGR
-8.7%/yr
Annual compound
Percentile
P89
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202510.75%
2024-64.84%
20230.30%
202214.11%
2021-3.61%
2020-25.75%
2019-26.79%
2018-59.76%
2017-15.99%
20160.00%